Form 4 for AQST Aquestive Therapeutics, Inc.
Accepted 2024-03-11 00:00:00 ET · period of report 2024-03-07 · accession 0001214659-24-004303 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-11 | 2024-03-07 | AQST | Boyd Peter E. | See Remark | A - Grant | $0.00 | +86.2K | 246.0K | +54% | $0 |
| D | 2024-03-11 | 2024-03-07 | AQST | Boyd Peter E. | See Remark | A - Grant | $0.00 | +43.1K | 43.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-07 | A | A | 86,250 | $0.00 | 245,998 | D | — | — | (F1) The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. (F2) The original Form 4, filed on 3/9/23, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported the inclusion of shares for 59,532 shares owned when in fact 59,748 shares of the Issuer's common stock were owned. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects an increase in the number of shares reported as beneficially owned by the reporting person by 216 shares. |
| 2 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-03-07 | A | A | 43,125 | $0.00 | 43,125 | D | $5.68 · — to 2034-03-07 | 43,125 Common Stock | (F3) The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. |